Kaposi Sarcoma Developed During Corticosteroid Therapy in Patient with Idiopathic Thrombocytopenic Purpura.
- Author:
Kwang Hee CHO
1
;
Yeon Hee PARK
;
Seong Jun CHOI
;
Yoon Koo KANG
;
Jin Haeng CHUNG
;
Yong Kack KIM
;
Baek Yeol RYOO
Author Information
1. Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. ryooby@kcch.re.kr
- Publication Type:Case Report
- Keywords:
Kaposi sarcoma;
Idiopathic thrombocytopenic purpura;
cortico steroid
- MeSH:
Acquired Immunodeficiency Syndrome;
Autoimmune Diseases;
Drug Therapy, Combination;
Humans;
Incidence;
Purpura, Thrombocytopenic, Idiopathic*;
Sarcoma, Kaposi*;
Transplantation
- From:Korean Journal of Hematology
2002;37(1):76-79
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Kaposi sarcoma (KS) has attracted much attention recently because of its high incidence among patients with acquired immune deficiency syndrome. Other groups with a high risk of developing KS are renal transplant recipients treated with immunosuppressive drugs and, to a lesser extent, patients with autoimmune diseases. We report the case of a patient who developed KS during corticosteroid therapy for idiopathic thrombocytopenic purpura, which subsequently regressed with combination chemotherapy.
